Organization | Cooperative Clinical Trials in Pediatric Transplantation

Cooperative Clinical Trials in Pediatric Transplantation Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial

1998

NCT00005009

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2006

Timeline

NOW

Now

Alternative names

Cooperative Clinical Trials in Pediatric Transplantation (CCTPT)

Active Ingredients

Drugs in Phase 2 Trials (11)

alemtuzumab (campath) (1 trial)

basiliximab (Simulect) (1 trial)

cyclosporine (sandimmune) (1 trial)

methylprednisolone (medrol) (1 trial)

mycophenolate (CellCept) (1 trial)

prednisone (meticorten) (1 trial)

rituximab (rituxan) (1 trial)

sirolimus (rapamune) (2 trials)

sodium chloride (1 trial)

tacrolimus (prograf) (2 trials)

trimethoprim (1 trial)

Drugs in Phase 1 Trials (1)

live attenuated varicella vaccine (Varivax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Herpes Zoster (Phase 1)

Kidney Failure, Chronic (Phase 2)

Renal Insufficiency (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 4
# of Trial APIs: 12